Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Dec;31(12):1867–1870. doi: 10.1128/aac.31.12.1867

Antifungal susceptibility tests.

J N Galgiani 1
PMCID: PMC175816  PMID: 3326524

Full text

PDF
1867

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aerts F., De Brabander M., van den Bossche H., van Cutsem J., Borgers M. The activity of ketoconazole in mixed cultures of fungi and human fibroblasts. Mykosen. 1980 Feb;23(2):53–67. doi: 10.1111/j.1439-0507.1980.tb02581.x. [DOI] [PubMed] [Google Scholar]
  2. Bannatyne R. M., Cheung R. Susceptibility of Canadida albicans to miconazole. Antimicrob Agents Chemother. 1978 Jun;13(6):1040–1041. doi: 10.1128/aac.13.6.1040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Block E. R., Jennings A. E., Bennett J. E. Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine. Antimicrob Agents Chemother. 1973 Oct;4(4):392–395. doi: 10.1128/aac.4.4.392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brass C., Shainhouse J. Z., Stevens D. A. Variability of agar dilution-replicator method of yeast susceptibility testing. Antimicrob Agents Chemother. 1979 Jun;15(6):763–768. doi: 10.1128/aac.15.6.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Calhoun D. L., Galgiani J. N. Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media. Antimicrob Agents Chemother. 1984 Sep;26(3):364–367. doi: 10.1128/aac.26.3.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dismukes W. E., Bennett J. E., Drutz D. J., Graybill J. R., Remington J. S., Stevens D. A. Criteria for evaluation of therapeutic response to antifungal drugs. Rev Infect Dis. 1980 Jul-Aug;2(4):535–545. doi: 10.1093/clinids/2.4.535. [DOI] [PubMed] [Google Scholar]
  7. Doern G. V., Tubert T. A., Chapin K., Rinaldi M. G. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts. J Clin Microbiol. 1986 Oct;24(4):507–511. doi: 10.1128/jcm.24.4.507-511.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ericsson H. M., Sherris J. C. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;217(Suppl):1+–1+. [PubMed] [Google Scholar]
  9. Galgiani J. N., Reiser J., Brass C., Espinel-Ingroff A., Gordon M. A., Kerkering T. M. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob Agents Chemother. 1987 Sep;31(9):1343–1347. doi: 10.1128/aac.31.9.1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Galgiani J. N., Stevens D. A. Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size. Antimicrob Agents Chemother. 1976 Oct;10(4):721–728. doi: 10.1128/aac.10.4.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Galgiani J. N., Yturralde C. A., Dugger K. O. Susceptibility of Candida albicans to flucytosine when tested in different formulations of yeast nitrogen base broth. Diagn Microbiol Infect Dis. 1986 Sep;5(3):273–276. doi: 10.1016/0732-8893(86)90012-x. [DOI] [PubMed] [Google Scholar]
  12. Galgiant J. N., Stevens D. A. Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods. Antimicrob Agents Chemother. 1978 Feb;13(2):249–254. doi: 10.1128/aac.13.2.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hoeprich P. D., Finn P. D. Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis. 1972 Oct;126(4):353–361. doi: 10.1093/infdis/126.4.353. [DOI] [PubMed] [Google Scholar]
  14. Holt R. J., Newman R. L. Laboratory assessment of the antimycotic drug clotrimazole. J Clin Pathol. 1972 Dec;25(12):1089–1097. doi: 10.1136/jcp.25.12.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Johnson B., White R. J., Williamson G. M. Factors influencing the susceptibility of Candida albicans to the polyenoic antibiotics nystatin and amphotericin B. J Gen Microbiol. 1978 Feb;104(2):325–333. doi: 10.1099/00221287-104-2-325. [DOI] [PubMed] [Google Scholar]
  16. MacKerrow S. D., Merry J. M., Hoeprich P. D. Effect of buffers on testing of Candida species susceptibility to flucytosine. J Clin Microbiol. 1987 May;25(5):885–888. doi: 10.1128/jcm.25.5.885-888.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mazens M. F., Andrews G. P., Bartlett R. C. Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B. Antimicrob Agents Chemother. 1979 Mar;15(3):475–477. doi: 10.1128/aac.15.3.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Minagawa H., Kitaura K., Nakamizo N. Effects of pH on the activity of ketoconazole against Candida albicans. Antimicrob Agents Chemother. 1983 Jan;23(1):105–107. doi: 10.1128/aac.23.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. O'Day D. M., Ray W. A., Robinson R. D., Head W. S. Correlation of in vitro and in vivo susceptibility of Candida albicans to amphotericin B and natamycin. Invest Ophthalmol Vis Sci. 1987 Mar;28(3):596–603. [PubMed] [Google Scholar]
  20. Odds F. C. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro. Antimicrob Agents Chemother. 1982 Nov;22(5):763–770. doi: 10.1128/aac.22.5.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Polak A., Grenson M. Interference between the uptake of pyrimidines and purines in yeasts. Pathol Microbiol (Basel) 1973;39(1):37–38. doi: 10.1159/000162618. [DOI] [PubMed] [Google Scholar]
  22. Polak A., Odds F. C., Lüdin E., Scholer H. J. Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis model. Chemotherapy. 1985;31(5):395–404. doi: 10.1159/000238365. [DOI] [PubMed] [Google Scholar]
  23. Polak A., Scholer H. J. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy. 1975;21(3-4):113–130. doi: 10.1159/000221854. [DOI] [PubMed] [Google Scholar]
  24. Radetsky M., Wheeler R. C., Roe M. H., Todd J. K. Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome. J Clin Microbiol. 1986 Oct;24(4):600–606. doi: 10.1128/jcm.24.4.600-606.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rogers T. E., Galgiani J. N. Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 1986 Sep;30(3):418–422. doi: 10.1128/aac.30.3.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Shadomy S., Paxton L., Espinel-Ingroff A., Shadomy H. J. In vitro studies with miconazole and miconazole nitrate. J Antimicrob Chemother. 1977 Mar;3(2):147–152. doi: 10.1093/jac/3.2.147. [DOI] [PubMed] [Google Scholar]
  27. Stiller R. L., Bennett J. E., Scholer H. J., Wall M., Polak A., Stevens D. A. Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. J Infect Dis. 1983 Jun;147(6):1070–1077. doi: 10.1093/infdis/147.6.1070. [DOI] [PubMed] [Google Scholar]
  28. Utz C. J., Shadomy S. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing. J Infect Dis. 1977 Jun;135(6):970–974. doi: 10.1093/infdis/135.6.970. [DOI] [PubMed] [Google Scholar]
  29. Utz C. J., White S., Shadomy S. New medium for in vitro susceptibility studies with amphotericin B. Antimicrob Agents Chemother. 1976 Oct;10(4):776–777. doi: 10.1128/aac.10.4.776. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES